dockets: FDA-2024-E-4125
This data as json
| id | agency_id | title | docket_type | last_modified | object_id | rin | dkabstract | category | subtype | keywords | program | short_title | effective_date | organization | attrs_raw | attr_source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2024-E-4125 | FDA | Patent Term Extension Application for ANKTIVA® (nogapendekin alfa inbakicept-pmln), Patent No. 8,507,222 | Nonrulemaking | 2026-09-09T13:12:52Z | 0b000064866b32e8 | list_pull |
Links from other tables
- 5 rows from docket_id in documents